These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 748092)

  • 21. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glucagon and of insulin on serum free fatty acids in normal and depancreatized dogs.
    Whitty AJ; Shima K; Trubow M; Foà PP
    Proc Soc Exp Biol Med; 1969 Jan; 130(1):55-61. PubMed ID: 5762527
    [No Abstract]   [Full Text] [Related]  

  • 23. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of exercise-induced hypoglycemia in depancreatized dogs maintained on long-acting insulin.
    Kawamori R; Vranic M
    J Clin Invest; 1977 Feb; 59(2):331-7. PubMed ID: 833280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of adrenergic agents on the secretion of gastrointestinal immunoreactive glucagon in depancreatized dogs.
    Yoshida T; Kondo M
    Diabetes; 1980 May; 29(5):355-60. PubMed ID: 6103854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of glucagon on glucose turnover and plasma free fatty acids in depancreatized dogs maintained on matched insulin infusions.
    Cherrington A; Vranic M; Fono P; Kovacevic N
    Can J Physiol Pharmacol; 1972 Oct; 50(10):946-54. PubMed ID: 4637182
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs.
    Cherrington AD; Vranic M
    Metabolism; 1974 Aug; 23(8):729-44. PubMed ID: 4851653
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia.
    Imamura T; Koffler M; Helderman JH; Prince D; Thirlby R; Inman L; Unger RH
    Diabetes; 1988 May; 37(5):600-9. PubMed ID: 3282947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of intravenous administration of fat emulsion to depancreatized dogs].
    Tsubakimoto R
    Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1997-2009. PubMed ID: 3148108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis RM; Hartley CJ; Entman ML; Field JB
    Diabetes; 1984 Oct; 33(10):984-90. PubMed ID: 6383906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
    Cieslak SR; Hazelwood RL
    Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.
    Vranic M; Pek S; Kawamori R
    Diabetes; 1974 Nov; 23(11):905-12. PubMed ID: 4430418
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
    Altszuler N; Gottlieb B; Hampshire J
    Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of gastric glucagon immunoreactivity in pancreatectomized dogs.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Jpn J Surg; 1980 Sep; 10(3):255-60. PubMed ID: 7012409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
    Colca JR; Hazelwood RL
    J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dog.
    Connolly CC; Ivy RE; Adkins-Marshall BA; Dobbins RL; Neal DW; Williams PE; Cherrington AD
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):45-56. PubMed ID: 8792101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intravenously administered fat emulsion on liver function in totally depancreatized dogs.
    Sudo T; Tsubakimoto R; Miyamoto M; Bessho H; Kanazawa H; Yasuda C; Fukunishi K; Uchida T; Kawamura M; Kuyama T
    Nihon Geka Hokan; 1990 Mar; 59(2):105-15. PubMed ID: 2130772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depancreatized dogs.
    Giacca A; Gupta R; Efendic S; Hall K; Skottner A; Lickley L; Vranic M
    Diabetes; 1990 Mar; 39(3):340-7. PubMed ID: 2407583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.